Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 2 September 2022, 14:33 HKT/SGT
Younger Colorectal Cancer Population Highlights the Importance of Early Screening, Highly Sensitive Test Product Prenetics has Launched the Market

HONG KONG, Sept 2, 2022 - (ACN Newswire) - Colorectal cancer (CRC) has become one of the main cancers threatening the health of human beings. In the United States and China, CRC has ranked among the top three cancers that lead to death.

CRC screening has been proven to be one of the most effective tools for preventing colorectal cancer. Research indicated that since screening was first recommended in 1980 in the United States, the incidence rate of CRC has dropped by 40%. Meanwhile, it's also important to follow the updated evidence, ensuring that the screening is suitable for the people who benefit most.

The onset of the Disease Tends to be Younger
The latest research has indicated that 94% of new CRC cases occur in adults over 45 years old. Among these, the number of new-onset and death cases occurring in individuals under the age of 50 has increased a lot. CRC diagnosis among younger adults is growing.

Therefore, National Comprehensive Cancer Network (NCCN) has updated its guidance in 2021, suggesting that people at average risk shall conduct screening from the age of 45.

U.S. Preventive Services Task Force (USPSTF) also pointed out that all asymptomatic adults aged 45 years old or above are exposed to CRC risks. Even without high-risk factors, they're recommended to take CRC screening.

Although the incidence rate of CRC is as high as thyroid cancer and breast cancer, the chance of treating CRC is better at an early age. It is very important to early find and treats the disease to ensure a higher survival rate. Research by the world-leading diagnosis and genetic health testing company Prenetics (PRE.O) showed that the 5-year survival rate of stage I and II CRC is up to 90% and stage III is 72.8%. It falls to 15.1% for stage IV CRC.

Despite the significantly higher survival rate in the early treatment of CRC, unfortunately, nearly half of the CRC cases are detected in the advanced stage, leading to extremely difficult treatment. Lacking a convenient and highly effective detection method is the vital cause of this phenomenon.

Significant Reform of CRC Detection
CRC screening has always relied on invasive detection methods including colonoscopy. Since such detection may cause pain or discomfort, some patients refuse the screening.

With the rising popularity of genetic detection science, CRC screening has welcomed a significant reform. Currently, a non-invasive and at-home screening test product - ColoClear has been introduced by Prenetics and New Horizon Health to the Southeast Asia market, which can detect pre-cancerous lesions and early, middle, and advanced stage CRC in an effective way.

Combining advanced stool DNA technology with a fecal immunochemical test (FIT), ColoClear is easier, cheaper, and simpler and has high sensitivity, up to 96%, which is comparable to traditional colonoscopy.

On top of ColoClear, CircleDNA, a home health diagnosis product of Prenetics gives over 500 test reports in 20 categories, which plays an important role in the early detection of cancer and other potential disease risks.

Topic: Press release summary Sectors: BioTech, Healthcare & Pharm
From the Asia Corporate News Network

Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Latest Press Releases
Q2 Metals Concludes Its 2024 Winter Drill Program at the Mia Lithium Property, James Bay Territory, Quebec, Canada  
Feb 27, 2024 21:09 HKT/SGT
U.S. Polo Assn. Supports 2024 U.S. Open Women's Polo Championship(R) Airing on ESPN  
Feb 27, 2024 21:00 HKT/SGT
Tuxera Expands Collaboration With Microsoft on New SMB Licensing Solution  
Feb 27, 2024 21:00 HKT/SGT
Genetec Sets the Stage for Higher Growth Following a Strong Q3FY2024 Performance  
Feb 27, 2024 20:00 HKT/SGT
HKTDC Hong Kong International Diamond, Gem and Pearl Show opens at AsiaWorld-Expo today  
Feb 27, 2024 20:00 HKT/SGT
DOCOMO to Conduct Open RAN Field Trials with Ooredoo, Smart and StarHub  
Tuesday, February 27, 2024 6:53:00 PM
CleverTap partners with Zoomcar to drive customer engagement on their app  
Tuesday, February 27, 2024 5:00:00 PM
Digitalization Empowering Foreign Trade Shipping - Nanhua Logistics, a COSCO Shipping Group Subsidiary, Partners with Bravowhale Technology to Spearhead the Online Implementation of ESG Compliance Standards  
Feb 27, 2024 10:56 HKT/SGT
Mitsubishi Electric Building Solutions to Supply Elevators and Escalators for New Capital Relocation Project in Indonesia  
Tuesday, February 27, 2024 10:00:00 AM
Award Winning Creative Director Guan Hin Tay Unveils Pioneering Book 'COLLIDE: Embracing Conflict to Boost Creativity,' Published by Penguin Random House SEA  
Feb 27, 2024 09:45 HKT/SGT
More Press release >>
More >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: